Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Rwanda: Akagera Medicines Gets Rwf11.5bn Grant to Advance TB Vaccine Trials

[New Times] Akagera Medicines, a biotechnology company majority-owned by Rwandans, has secured an additional $7.8 million (approximately Rwf11.5 billion) from the Gates Foundation to advance the development of a tuberculosis vaccine towards its first human clinical trial.

We haven't written up this one. AllAfrica Health has the full story — the link below goes straight to it.

Read the original at allafrica.com →

More in Health & Medicine

More from Thursday 19 November →